Services

Uptake screening as a service, in the organism that matters to you

DrugUptech operates as a contract research organisation. You send compounds; we run the assays, benchmark them and return decision-ready reports.

Antimicrobial discovery

Get past the Gram-negative wall

Decades of target-based antibacterial campaigns produced potent enzyme inhibitors that never became drugs because they could not accumulate in whole cells, especially Gram-negatives. Re-engineering a compound to accumulate can restore activity, but only if accumulation is measured early enough to guide chemistry.

  • Accumulation ranking of hits and analogues in ESKAPE pathogens, MRSA, Mycobacterium smegmatis, Candida and your own clinical isolates.
  • Efflux vs permeability using energy supplementation.
  • Uptake paired with MIC so you see whether low potency is a target problem or a delivery problem.
  • Benchmarked against colistin, ceftazidime, rifampicin, gentamicin, tetracycline and ciprofloxacin.
Rifampicin accumulation at 25 micromolar in AYE, PA01 and Klebsiella
Rifampicin, 25 µM, three Gram-negative pathogens on one plate. Mean ± SD, n = 3.
Agrochemicals & biostimulants

Protoplast viability and uptake analysis

Our plant work is a specialism in its own right: viability-controlled uptake measurements in Arabidopsis Col-0 protoplasts, with leaf-tissue assays for foliar questions. It has its own page.

Go to Plants & protoplasts
Micrograph of freshly isolated Arabidopsis thaliana Col-0 protoplasts
Freshly isolated Arabidopsis thaliana Col-0 protoplasts, routinely prepared in-house.
Small-molecule drug discovery

Cell-based uptake from hit triage to lead optimisation

Early failures cost most when they are discovered late. Screening uptake alongside potency in the relevant human cell line de-risks candidate selection and gives medicinal chemists a measurable property to optimise.

  • Uptake screening in Caco-2, HEK293T and other lines, including resistant derivatives.
  • Kinetic profiling to separate fast passive entry from slower carrier-mediated uptake.
  • Efflux liability assessment with transporter inhibitors or engineered lines.
  • Cytotoxicity paired with uptake so exposure and effect are measured in the same experiment.

Where uptake data pays back

Hit-to-lead and lead-optimisation stages typically cost several million dollars each. A compound that fails for accumulation after those stages wastes all of it. An uptake screen at hit identification costs a fraction of one analogue series and removes the liability before it compounds.

Antibody-drug conjugates and larger modalities

We are extending the platform to nanobodies and antibody-drug conjugates. If you have a conjugate uptake question, talk to us about a pilot.

Academic research

For research groups

We collaborate with academic labs on uptake, efflux and membrane-interaction questions, from single-compound mechanism studies to library screens. Grant-costed projects, co-authored outputs and method transfer are all possible.

Assay menu

What we offer

ServiceWhat is measuredTypical scope
Uptake screen% accumulation and kinetics for each compound in one organism or cell line, benchmarkedFrom 10 compounds per assay
Uptake + viability / efficacyUptake as above plus MIC, growth inhibition or cytotoxicity in the same programmeFrom 10 compounds per assay
Efflux contributionUptake with and without energy supplementation or efflux inhibitorsPer compound, per organism
Multi-organism panelThe same compounds across a panel of strains, species or cell linesPer panel
Protoplast viability + uptakeViability-controlled uptake in Col-0 protoplasts by real-time fluorescent detection; see PlantsPer compound set
Leaf tissue uptakeFoliar uptake over hours in leaf discs from any plant species, formulation and adjuvant comparisonsPer active or formulation set
Custom system set-upValidation of your own strain, isolate, cell line or tissue on the platformOne-off set-up

Every project is scoped individually around your compounds, organisms and decision points. Make an enquiry and we will come back with a proposal.

Project timeline

From first call to full report in about two months

0

Project start

Scoping call, compounds received, organisms and readouts confirmed.

W3

Initial set-up report

Detection mode per compound, MIC50 or dose range, benchmark performance.

M2

Full uptake report

Accumulation, kinetics, efflux contribution, viability or efficacy, with raw data.

Ready to see how much of your compound gets in?

Tell us about your compounds and target organisms. We will scope the assay, agree the readouts and return a set-up report within three weeks.